이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Mangalam Drugs & Organics 관리
관리 기준 확인 3/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Govardhan Dhoot
최고 경영자
₹2.0m
총 보상
| CEO 급여 비율 | 100.0% |
| CEO 임기 | 28.3yrs |
| CEO 소유권 | 6.8% |
| 경영진 평균 재임 기간 | 데이터 없음 |
| 이사회 평균 재임 기간 | 6.5yrs |
최근 관리 업데이트
Recent updates
Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues Are Not Doing Enough For Some Investors
Aug 13
A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
May 23Little Excitement Around Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Revenues As Shares Take 25% Pounding
Mar 28Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Shares Lagging The Industry But So Is The Business
Feb 07Estimating The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Oct 20Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Mar 29These 4 Measures Indicate That Mangalam Drugs & Organics (NSE:MANGALAM) Is Using Debt Extensively
May 31A Look At The Fair Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Apr 06We Think Mangalam Drugs & Organics (NSE:MANGALAM) Is Taking Some Risk With Its Debt
Jan 03Here's Why Mangalam Drugs & Organics (NSE:MANGALAM) Can Manage Its Debt Responsibly
May 23Is Mangalam Drugs & Organics (NSE:MANGALAM) A Risky Investment?
Jan 04Do Its Financials Have Any Role To Play In Driving Mangalam Drugs & Organics Limited's (NSE:MANGALAM) Stock Up Recently?
Nov 12
A Look At The Intrinsic Value Of Mangalam Drugs & Organics Limited (NSE:MANGALAM)
Sep 20Does Mangalam Drugs & Organics's (NSE:MANGALAM) Statutory Profit Adequately Reflect Its Underlying Profit?
Aug 05We Think Mangalam Drugs & Organics (NSE:MANGALAM) Can Stay On Top Of Its Debt
Jul 01CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -₹91m |
| Dec 31 2023 | n/a | n/a | -₹170m |
| Sep 30 2023 | n/a | n/a | -₹171m |
| Jun 30 2023 | n/a | n/a | -₹113m |
| Mar 31 2023 | ₹2m | ₹2m | ₹13m |
| Dec 31 2022 | n/a | n/a | ₹123m |
| Sep 30 2022 | n/a | n/a | ₹159m |
| Jun 30 2022 | n/a | n/a | ₹182m |
| Mar 31 2022 | ₹2m | ₹2m | ₹197m |
| Dec 31 2021 | n/a | n/a | ₹151m |
| Sep 30 2021 | n/a | n/a | ₹175m |
| Jun 30 2021 | n/a | n/a | ₹241m |
| Mar 31 2021 | ₹2m | n/a | ₹280m |
| Dec 31 2020 | n/a | n/a | ₹309m |
| Sep 30 2020 | n/a | n/a | ₹261m |
| Jun 30 2020 | n/a | n/a | ₹158m |
| Mar 31 2020 | ₹5m | ₹2m | ₹83m |
| Dec 31 2019 | n/a | n/a | -₹28m |
| Sep 30 2019 | n/a | n/a | -₹89m |
| Jun 30 2019 | n/a | n/a | -₹80m |
| Mar 31 2019 | ₹2m | ₹2m | -₹80m |
| Dec 31 2018 | n/a | n/a | ₹10m |
| Sep 30 2018 | n/a | n/a | ₹114m |
| Jun 30 2018 | n/a | n/a | ₹164m |
| Mar 31 2018 | ₹2m | ₹2m | ₹199m |
보상 대 시장: Govardhan 의 총 보상 ($USD 23.95K ) Indian 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 38.49K ).
보상과 수익: Govardhan 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Govardhan Dhoot (71 yo)
28.3yrs
테뉴어
₹2,000,000
보상
Mr. Govardhan Murlidhar Dhoot serves as the Chairman of the Board and Managing Director at Mangalam Drugs & Organics Limited and has been its Executive Director since April 16, 1996.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman & MD | 28.3yrs | ₹2.00m | 6.81% ₹ 134.6m | |
| Whole-Time Director | 9.3yrs | ₹600.00k | 3.57% ₹ 70.6m | |
| Independent Director | 6.8yrs | ₹36.00k | 데이터 없음 | |
| Non-Executive Independent Director | 6.3yrs | ₹42.00k | 데이터 없음 | |
| Independent Non-Executive Director | 3.4yrs | ₹24.00k | 데이터 없음 | |
| Non-Executive Non- Independent Director | 2.4yrs | ₹16.00k | 데이터 없음 |
6.5yrs
평균 재임 기간
69yo
평균 연령
경험이 풍부한 이사회: MANGALAM 의 이사회는 경험(평균 재직 기간 6.3 년)으로 간주됩니다.